Скачать или смотреть Joyce Shoffner, Patient in Duke's Fraudulent Trial, Speaks

Joyce Shoffner would never have predicted that Duke University, an institution she revered and at one time worked for, would put her in a breast cancer clinical trial testing a fraudulent technology.

“They advertised publicly that this science offered an 80 percent cure rate,” Shoffner said. “To have the type of cancer I had, I was just going to do that, there’s nobody that’s going to stop me, because this was what I was told and this was what I believed was going to happen.”

In July 2008, Shoffner became patient No. 1 in the trial that promised to choose the best therapy for the unique characteristics of her disease. Alas, the groundbreaking genomic predictors pioneered by Anil Potti and his mentor Joseph Nevins, which the trials were testing, would turn out to be fraudulent.

Read the full story on The Cancer Letter: cancerletter.com/articles/20150522_1